dolichols and Non-alcoholic-Fatty-Liver-Disease

dolichols has been researched along with Non-alcoholic-Fatty-Liver-Disease* in 1 studies

Reviews

1 review(s) available for dolichols and Non-alcoholic-Fatty-Liver-Disease

ArticleYear
[Effectiveness of the new plant hepatoprotector--Ropren in patients with non-alcoholic steatohepatitis].
    Eksperimental'naia i klinicheskaia gastroenterologiia = Experimental & clinical gastroenterology, 2010, Issue:7

    Liver damage causes serious metabolic disorders, immune response, detoxification functions and antimicrobial protection. Therefore, the problem of finding new high effective drugs for the restoration and normalization of liver function is extremely urgent. This article presents a new domestic plant hepatoprotector Ropren, which is a biopolymer polyprenols isolated from the green of pine and spruce, and an analog of the endogenous lipid--dolichol. Presented the Ropren efficiency in patients with nonalcoholic steatohepatitis. The drug reduces the clinical and biochemical disease activity, contributes to the normalization of lipid profile. The resulting decrease in the index treatment of fibrosis, determined by indirect transient elastometry, indicates an increase in the elasticity of the liver and reducing the risk of developing cirrhosis.

    Topics: Dolichols; Fatty Liver; Humans; Liver; Liver Cirrhosis; Non-alcoholic Fatty Liver Disease; Plant Preparations

2010